Clinical Trial Update: Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of a latanoprost-eluting contact lens for treating glaucoma and ocular hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Latanoprost-eluting contact lens (latanoprost)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Glaucoma, Ocular Hypertension | Phase 1 | Status: TERMINATED